IL223248A0 - Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray - Google Patents

Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray

Info

Publication number
IL223248A0
IL223248A0 IL223248A IL22324812A IL223248A0 IL 223248 A0 IL223248 A0 IL 223248A0 IL 223248 A IL223248 A IL 223248A IL 22324812 A IL22324812 A IL 22324812A IL 223248 A0 IL223248 A0 IL 223248A0
Authority
IL
Israel
Prior art keywords
cell mass
cancer
sensitivity
drug
tissue
Prior art date
Application number
IL223248A
Other languages
English (en)
Original Assignee
Renaissance Energy Invest Co Ltd
Osaka Prefectural Hospital Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2010120827A external-priority patent/JP5809782B2/ja
Application filed by Renaissance Energy Invest Co Ltd, Osaka Prefectural Hospital Organization filed Critical Renaissance Energy Invest Co Ltd
Publication of IL223248A0 publication Critical patent/IL223248A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL223248A 2010-05-26 2012-11-26 Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray IL223248A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010120827A JP5809782B2 (ja) 2009-12-24 2010-05-26 癌組織由来細胞塊または癌細胞凝集塊の薬剤または放射線感受性評価方法
PCT/JP2011/062075 WO2011149013A1 (ja) 2010-05-26 2011-05-26 癌組織由来細胞塊または癌細胞凝集塊の薬剤または放射線感受性評価方法

Publications (1)

Publication Number Publication Date
IL223248A0 true IL223248A0 (en) 2013-02-03

Family

ID=45015754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL223248A IL223248A0 (en) 2010-05-26 2012-11-26 Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray

Country Status (3)

Country Link
KR (1) KR20130024904A (ko)
IL (1) IL223248A0 (ko)
WO (1) WO2011149013A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013093954A1 (ja) * 2011-12-19 2013-06-27 ヤマハ発動機株式会社 対象物選別装置および対象物選別方法
JP5827696B2 (ja) * 2011-12-20 2015-12-02 ヤマハ発動機株式会社 対象物選別装置および対象物選別方法
KR101674468B1 (ko) * 2013-05-07 2016-11-10 재단법인 아산사회복지재단 환자유래 일차배양 암세포의 배양방법 및 일차배양 암세포를 이용하여 제작된 암 환자와 동일한 이종 이식 동물모델의 구축 방법
JP2017205021A (ja) * 2014-09-26 2017-11-24 Jsr株式会社 初代癌細胞のスフェロイド作製方法、スフェロイド、スクリーニング方法、及び、診断方法
JP2016136848A (ja) * 2015-01-26 2016-08-04 富士フイルム株式会社 薬剤の評価方法及び薬剤スクリーニング方法
US11549100B2 (en) * 2017-03-16 2023-01-10 Lsi Medience Corporation Three-dimensional culture of primary cancer cells using tumor tissue
SG11202002570WA (en) * 2017-10-31 2020-04-29 Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh Methods for determining selectivity of test compounds
WO2019230756A1 (ja) * 2018-05-30 2019-12-05 国立大学法人大阪大学 ヒト血管の形成、構造または機能に影響を及ぼす物質のスクリーニング方法、およびヒト血管の製造方法
US20240218417A1 (en) * 2021-11-24 2024-07-04 MBD Co., Ltd. Radiation sensitivity diagnosis method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5652809B2 (ja) * 2009-03-02 2015-01-14 株式会社ルネッサンス・エナジー・インベストメント 癌組織由来細胞塊およびその調製法
JP2011115106A (ja) * 2009-12-04 2011-06-16 Rei Medical Co Ltd 癌細胞凝集塊およびその調製法

Also Published As

Publication number Publication date
WO2011149013A1 (ja) 2011-12-01
KR20130024904A (ko) 2013-03-08

Similar Documents

Publication Publication Date Title
IL223248A0 (en) Method for evaluation of sensitivity of cancer-tissue-derived cell mass or aggregated cancer cell mass to drug or radioactive ray
GB2484621B (en) Gamma ray detectors having azimuthal sensitivity
GB2506060B (en) Apparatuses and methods for detection of radiation including neutrons and gamma rays
EP2703843A4 (en) CALIBRATION DEVICE FOR PHOTON COUNT RAY DETECTOR AND CALIBRATION METHOD THEREOF
GB2499709B (en) Lithium based scintillators for neutron detection
EP2539697A4 (en) A high-energy x-ray spectroscopy-based inspection system and methods to determine the atomic number of materials
EP2783204A4 (en) X-RAY DISTANCE INDICATOR AND ASSOCIATED METHODS
EP2618154A4 (en) METHOD OF DETERMINING THE EFFICACY OF A MEDICAMENT CONTAINING ANTIBODY AS COMPONENT
EP2795371A4 (en) NEUTRON DETECTION USING A SHIELDED GAMMA RADIATOR DETECTOR
EP2603926A4 (en) DETECTOR FOR LOADED PARTICLES
HK1172092A1 (en) Gamma camera and method for detecting radiation ray by utilizing same
ZA201207895B (en) Method of calibrating excore detectors in a nuclear reactor
EP2700980A4 (en) BORN-LAYERED NEUTRON DETECTOR AND MANUFACTURING METHOD THEREFOR
GB201107076D0 (en) Neutron detector
GB201410896D0 (en) Detector and method for simultaneously detecting gamma ray and neutron ray using same
EP2967465A4 (en) SYSTEM FOR DETECTING GAMMA RADIATION OF A RADIOACTIVE ANALYTE
GB2494794B (en) Radioactive/nuclear threat monitoring using long detectors
EP2565682A4 (en) NEUTRON SCINTILLATOR AND NEUTRON DETECTOR
IL237286A0 (en) An energy-sensitive fast neutron imaging detector and an energy-sensitive fast neutron detection method
GB2506320B (en) Measurement of formation porosity using a single gamma ray detector
GB2494231B (en) On-chip radiation dosimeter background
EP2569654A4 (en) NEUTRONOUS DETECTORS FOR ACTIVE QUERIES
GB201413128D0 (en) Method and decive for measuring effective atomic number of object
GB201110371D0 (en) Materials and methods for determining sensitivity potential of compounds
IL233085A0 (en) Neutron detector with fast position-direction sensing